Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-25-123775
Filing Date
2025-12-22
Accepted
2025-12-22 16:39:09
Documents
2
Period of Report
2025-12-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2534102-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2534102-1_3seq1.xml 3 1602
2 EXHIBIT 24 tm2534102d1_ex24.htm EX-24 7556
  Complete submission text file 0001104659-25-123775.txt   10599
Mailing Address C/O SICOR INC 19 HUGHES IRVINE CA 92618-1902
Business Address
STOVER JACK E (Reporting) CIK: 0001203603 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40363 | Film No.: 251592997

Mailing Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109
Business Address 6 LIBERTY SQUARE #2382 BOSTON MA 02109 857-301-6857
Transcode Therapeutics, Inc. (Issuer) CIK: 0001829635 (see all company filings)

EIN.: 811065054 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)